Axcella Stock Performance

AXLA
 Stock
  

USD 2.69  0.04  1.51%   

Axcella Health holds a performance score of 11 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.1843, which signifies a somewhat significant risk relative to the market. Let's try to break down what Axcella's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Axcella Health will likely underperform. Although it is vital to follow Axcella Health historical returns, it is good to be conservative about what you can do with the information regarding equity current trending patterns. Our philosophy in foreseeing future performance of any stock is to look not only at its past charts but also at the business as a whole, including all fundamental and technical indicators. To evaluate if Axcella Health expected return of 1.11 will be sustainable into the future, we have found twenty-eight different technical indicators, which can help you to check if the expected returns are sustainable. Use Axcella Health sortino ratio, semi variance, and the relationship between the information ratio and value at risk to analyze future returns on Axcella Health.
  
Axcella Performance
11 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Axcella Health are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, Axcella Health sustained solid returns over the last few months and may actually be approaching a breakup point. ...more

Axcella Price Channel

Quick Ratio4.88
Fifty Two Week Low1.3500
Target High Price19.00
Fifty Two Week High4.4000
Target Low Price7.00

Axcella Health Relative Risk vs. Return Landscape

If you would invest  160.00  in Axcella Health on May 18, 2022 and sell it today you would earn a total of  109.00  from holding Axcella Health or generate 68.13% return on investment over 90 days. Axcella Health is currently generating 1.1134% in daily expected returns and assumes 7.2361% risk (volatility on return distribution) over the 90 days horizon. In different words, 62% of stocks are less volatile than Axcella, and 79% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Axcella Health is expected to generate 6.18 times more return on investment than the market. However, the company is 6.18 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The DOW is currently generating roughly 0.11 per unit of risk.

Axcella Health Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Axcella Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Axcella Health, and traders can use it to determine the average amount a Axcella Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.1539

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsAXLA
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns
Estimated Market Risk
 7.24
  actual daily
 
 62 %
of total potential
 
6262
Expected Return
 1.11
  actual daily
 
 21 %
of total potential
 
2121
Risk-Adjusted Return
 0.15
  actual daily
 
 11 %
of total potential
 
1111
Based on monthly moving average Axcella Health is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Axcella Health by adding it to a well-diversified portfolio.

About Axcella Health Performance

To evaluate Axcella Health Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Axcella Health generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Axcella Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Axcella Health stock market performance in a much more refined way. At Macroaxis, we take it even further. The Macroaxis performance score is an integer between 0 and 100 that represents Axcella's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Return on Average Assets(0.85) (0.92) 
Return on Average Equity(1.54) (1.67) 
Return on Invested Capital(1.04) (1.13) 
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts. Axcella Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.

Things to note about Axcella Health

Checking the ongoing alerts about Axcella Health for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Axcella Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Axcella Health Alerts

Equity Alerts and Improvement Suggestions

Axcella Health is way too risky over 90 days horizon
Axcella Health appears to be risky and price may revert if volatility continues
Axcella Health has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (68.48 M).
Axcella Health currently holds about 63.22 M in cash with (56.94 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.2.
Axcella Health has a frail financial position based on the latest SEC disclosures
Roughly 65.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.marketscreener.com: Axcella Health Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID - Form 8-K - Marketscreener.com
Please continue to Trending Equities. Note that the Axcella Health information on this page should be used as a complementary analysis to other Axcella Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Axcella Stock analysis

When running Axcella Health price analysis, check to measure Axcella Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axcella Health is operating at the current time. Most of Axcella Health's value examination focuses on studying past and present price action to predict the probability of Axcella Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Axcella Health's price. Additionally, you may evaluate how the addition of Axcella Health to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Is Axcella Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axcella Health. If investors know Axcella will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axcella Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
122.5 M
Return On Assets
-0.68
Return On Equity
-2.57
The market value of Axcella Health is measured differently than its book value, which is the value of Axcella that is recorded on the company's balance sheet. Investors also form their own opinion of Axcella Health's value that differs from its market value or its book value, called intrinsic value, which is Axcella Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axcella Health's market value can be influenced by many factors that don't directly affect Axcella Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axcella Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Axcella Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axcella Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.